Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer

NCT00768755

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pfizer Investigational Site Huntsville, Alabama, United States
  • Pfizer Investigational Site Atlanta, Georgia, United States
  • Pfizer Investigational Site Decatur, Georgia, United States
  • Pfizer Investigational Site Macon, Georgia, United States
View all 52 locations
View Trial Details
Completed

A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC

NCT00743938

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Hematology Oncology, P.C. Stamford, Connecticut, United States
  • Mass General Hospital Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
View all 30 locations
View Trial Details
Completed

Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response

NCT01167244

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution Kashiwa-Shi, Chiba, Japan
  • Local Institution Osaka-Sayama-Shi, Osaka, Japan
  • Local Institution Sunto-Gun, Shizuoka, Japan
  • Local Institution Koto-Ku, Tokyo, Japan
View Trial Details
Completed

Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib

NCT00993499

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1200.70.34001 Boehringer Ingelheim Investigational Site Badalona (Barcelona), Spain
  • 1200.70.34008 Boehringer Ingelheim Investigational Site Barcelona, Spain
  • 1200.70.34009 Boehringer Ingelheim Investigational Site Barcelona, Spain
  • 1200.70.34006 Boehringer Ingelheim Investigational Site Girona, Spain
View Trial Details

Related conditions